Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

80

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Role of plasmin in metastatic tumors

Related Posts

HTRA1/lncRNA HTRA1-AS1 dominates in age- related macular degeneration reticular pseudodrusen genetic risk with no complement involvement

HTRA1/lncRNA HTRA1-AS1 dominates in age- related macula...

38

The N terminus-only function of adhesion GPCRs: emerging concepts

The N terminus-only function of adhesion GPCRs: emergin...

71

A multimodal vision knowledge graph of cardiovascular disease

A multimodal vision knowledge graph of cardiovascular d...

46